Reality is in the Results, and It Is No Surprise: Your ASP Tallies
In a recent Neltner News article, we asked for you to complete our short ASP "worksheet". We've had several responses from oncology/hematology practices, comparing what they are paying to the Medicare allowable. The results? No surprise: most physicians are paying way too much. We will continue to update this as we get more data from hematologists/oncologists across the country.
Now that you see the data, is it reality or myth that:
- Oncologists cannot purchase drugs at ASP or lower.
- Oncologists have been misled by industry representatives that oncologists are purchasing drugs at or below ASP.
The answer is reality, and you are proving it in your numbers. The table shows that most payments are red and blue. Red numbers denote payments of ASP+6% or higher; blue numbers denote payments between ASP and ASP+6%. There are few numbers in black which actually fall below ASP. Average costs are ranging from ASP + 3% to ASP + 22%.
Thank you for the responses we have received so far and please keep them coming. It is clear from what we have collected so far, that ASP is flawed. The more data we can collect, the stronger we will be in lobbying for change. The data, the reality, cannot be ignored.
For more information contact us:
Neltner Billing and Consulting
6463 Taylor Mill Road
Independence, KY 41051
888-635-8637
info@neltnerbilling.com
Latest News
-
06-24-11
-
05-17-11
-
05-05-11
-
02-16-11
-
12-13-10
-
07-28-10
-
06-14-10
-
04-16-10
-
12-01-09
